Atalanta Therapeutics

1 follower


Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Headquarters

Stage

Employees

Links

Org chart

Alicia Secor
President & CEO

Alicia Secor

Collapse
Aimee L. Jackson
Chief Scientific Officer
Morgan Molloy
Chief Corporate Development Officer
Bart G. Newland
General Counsel
Maurice Smith
Senior Director & Controller
Michele Keough
SVP, Program & Alliance Management
Stephen Burke
SVP, Human Resources
Guillermo Yudowski
VP, Biochemistry & Pharmacology, In vitro Biology
Kimberly Dougherty
Senior Director, Facilities & Operations
Brittany Ferdman
Purchasing Coordinator
Rudra Thaker
Bioinformatics Data Engineer
Mariam Traore
Associate Scientist II